NCT06099561 Intractable Self-harm-What Support is Effective?
| NCT ID | NCT06099561 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Region Skane |
| Condition | Self-harm |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2023-09-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2023-09-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this project is to evaluate a novel treatment program for individuals with intractable and lethal self-harm. The main questions are: 1: Is there, in individuals with intractable self-harm, a relevant improvement in daily functioning and is this improvement related to the provided interventions? The secondary research questions are: 2\. Is there, in individuals with intractable self-harm, a relevant improvement in frequency and severity of self-harm? 3\. Is there, in individuals with intractable self-harm, a relevant improvement in voluntary hospital admissions? 4\. Is there, in individuals with intractable self-harm, a relevant improvement in compulsary hospital admissions? 5\. Is there, in individuals with intractable self-harm, a relevant improvement in the use of medication pro re nata? 6\. Is there, in individuals with intractable self-harm, a relevant improvement in cost-effectiveness related to the provided interventions?
Eligibility Criteria
Inclusion Criteria: * Having tried or made serious attempt to try at least two different interventions with evidence to reduce self-harm, without sufficient reduction in suffering or self-harm Exclusion Criteria: * Need for translation services to complete measures or interviews * Not able to complete measures or interviews
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06099561 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Self-harm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06099561 currently recruiting?
Yes, NCT06099561 is actively recruiting participants. Contact the research team at magnus.per.nilsson@skane.se for enrollment information.
Where is the NCT06099561 trial being conducted?
This trial is being conducted at Lund, Sweden.
Who is sponsoring the NCT06099561 clinical trial?
NCT06099561 is sponsored by Region Skane. The trial plans to enroll 30 participants.